EverydayHealthLogo
Dr. Euan Ashley, MD

Dr. Euan Ashley, MD

Redwood City, CA

23 Years of Experience

Accepting patients

Affiliated with a Castle Connolly Top Hospital

    Who is Dr. Ashley, Cardiologist in Redwood City, CA?

    Dr. Euan Ashley, MD is a Cardiologist, who primarily practices in Redwood City, CA with 2 additional practice locations. He has been practicing for over 23 years. Dr. Ashley graduated from University of Glasgow Faculty of Medicine. Dr. Ashley is fluent in English, and is currently seeing new patients. Dr. Ashley’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Ashley’s office at (650) 498-5710.

    Where did Dr. Ashley go to medical school and complete their residency?

    • Medical School: University of Glasgow Faculty of Medicine

    What languages does Dr. Ashley speak?

    Dr. Ashley and their clinical team can communicate with patients in the following languages:

    • English

    What conditions does a Cardiologist like Dr. Ashley typically treat?

    As a Cardiologist, Dr. Ashley diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Ashley. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.

    Also known as:

    • Obstructive Hypertrophic Cardiomyopathy
    • Hypertrophic Cardiomyopathy
    • Dilated Cardiomyopathy
    • Cardiomyopathy
    • Other Cardiomyopathies
    • Familial dilated cardiomyopathy
    • X-linked dilated cardiomyopathy
    • HCM (Obstructive)
    • Thickened Heart Muscle with Obstruction
    • HCM
    • Thickened Heart Muscle
    • Enlarged heart muscle
    • DCM
    • Heart Muscle Disease
    • Enlarged Heart
    • Uncommon heart muscle diseases
    • Rare cardiomyopathy types

    ICD-10 Codes:

    • I421: Obstructive hypertrophic cardiomyopathy
    • I422: Other hypertrophic cardiomyopathy
    • I420: Dilated cardiomyopathy
    • I429: Cardiomyopathy, unspecified
    • I428: Other cardiomyopathies

    What procedures does a Cardiologist like Dr. Ashley typically perform?

    As a Cardiologist, procedures performed by Dr. Euan Ashley may include:

    Please contact Dr. Ashley's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.

    Does Dr. Ashley accept my insurance?

    Dr. Ashley accepts most major insurance plans. Important: Please call our office at (650) 498-5710 before your appointment to verify that your specific plan and network are accepted.

    What insurance plans does Dr. Ashley accept in Redwood City, CA?

    Dr. Ashley in Redwood City, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.

    Top Insurances

    • All Other Third Party

    • Blue Shield of California

    • Cigna Group

    • CVS Health (formerly Aetna)

    • Medicaid

    • Medicare

    • Other Provider Networks

    • State of California

    • UnitedHealth Group

    • Unknown

    View All Insurances

    Where is Dr. Ashley's office located?

    Dr. Euan Ashley's Primary Practice

    170 Alameda de las Pulgas

    Redwood City, CA 94062

    (650) 498-5710

    Get Directions

    Dr. Euan Ashley's Practice 2

    2585 Samaritan Dr

    San Jose, CA 95124

    Get Directions

    Dr. Euan Ashley's Practice 3

    5800 Hollis St

    Emeryville, CA 94608

    Get Directions

    Recognitions

    Publications

    Clinical interpretation and implications of whole-genome sequencing.

    , 2014

    APJ acts as a dual receptor in cardiac hypertrophy

    , 2012

    Persol Omics Profiling Reveals Dymic Molecular and Medical Phenotypes

    , 2012

    Phased Whole-Genome Genetic Risk in a Family Quartet Using a Major Allele Reference Sequence

    , 2011

    Clinical assessment incorporating a persol genome

    , 2010

    Unexplained double-chambered left ventricle associated with contracting right ventricular aneurysm

    , 2014

    A neural network approach to predicting outcomes

    , 2014

    Rat model of veno-arterial extracorporeal membrane oxygetion.

    , 2014

    The prognostic significance of heart rate recovery is not dependent upon maximal effort

    , 2013

    Race differences in ventricular remodeling and function among college football players.

    , 2013

    Taming Rare Variation With Known Biology in Long QT Syndrome.

    , 2013

    Impact of Cardiorespiratory Fitness on the Obesity Paradox in Patients With Heart Failure

    , 2013

    Validation of a cardiopulmory exercise test score in heart failure.

    , 2013

    Cardiopulmory and Noninvasive Hemodymic Responses to Exercise Predict Outcomes in Heart Failure

    , 2013

    A Clinical Approach to Inherited Hypertrophy The Use of Family History in Diagnosis

    , 2013

    Abnormal Calcium Handling Properties Underlie Familial Hypertrophic Cardiomyopathy Pathology in

    , 2013

    A meta-alysis of the prognostic significance of cardiopulmory exercise testing in patients with

    , 2013

    Cardiac Structural and Sarcomere Genes Associated With Cardiomyopathy Exhibit Marked Intolerance of

    , 2012

    Prognostic value of capnography during rest and exercise in patients with heart failure.

    , 2012

    Ventilatory Power A Novel Index That Enhances Prognostic Assessment of Patients With Heart Failure

    , 2012

    In Situ Optical Mapping of Voltage and Calcium in the Heart

    , 2012

    A public resource facilitating clinical use of genomes

    , 2012

    Persolized medicine: hope or hype?

    , 2012

    The Prognostic Utility of Cardiopulmory Exercise Testing St

    , 2012

    Prognostic Implications of Q Waves and T-Wave Inversion Associated With Early Repolarization

    , 2012

    Cell-Intrinsic Functiol Effects of the alpha

    , 2012

    Apelin Enhances Directed Cardiac Differentiation of Mouse and Human Embryonic Stem Cells

    , 2012

    Whole-Genome Sequencing in Persolized Therapeutics

    , 2012

    Systems-Based Approaches to Cardiovascular Biomarker Discovery

    , 2012

    Randomized Trial of Persol Genomics for Preventive Cardiology Design and Challenges

    , 2012

    Patient-Specific Induced Pluripotent Stem Cells as a Model for Familial Dilated Cardiomyopathy

    , 2012

    The prognostic value of early repolarization with ST-segment elevation in African Americans

    , 2012

    D Sequencing Clinical Applications of New D Sequencing Technologies

    , 2012

    Exercise oscillatory ventilation reflects diminished quality of life

    , 2011

    Early Repolarization in an Ambulatory Clinical Population

    , 2011

    The Impact of ST Elevation on Athletic Screening

    , 2011

    Interpretation of the Electrocardiogram of Young Athletes

    , 2011

    Hearts From DCD Donors Display Acceptable Biventricular Function After Heart Transplantation

    , 2011

    Systems biology of heart failure, challenges and hopes

    , 2011

    Genetic Alysis in Cardiovascular Disease A Clinical Perspective

    , 2011

    The concept of ventricular reserve in heart failure and pulmory hypertension

    , 2011

    Gene Coexpression Network Topology of Cardiac Development, Hypertrophy, and Failure

    , 2011

    BMP promotes motility and represses growth of smooth muscle cells by activation of tandem Wnt

    , 2011

    Drug Discovery in a Multidimensiol World: Systems, Patterns, and Networks

    , 2010

    Chromatin regulation by Brg1 underlies heart muscle development and disease

    , 2010

    Upregulation of the apelin

    , 2010

    Challenges in the clinical application of whole-genome sequencing

    , 2010

    Measurement Precision in the Optimization of Cardiac Resynchronization Therapy

    , 2010

    Defining the Limits of Athlete's Heart Implications for Screening in Diverse Populations

    , 2010

    Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young

    , 2010

    New insights for the diagnosis and magement of right ventricular failure

    , 2010

    Addition of the Electrocardiogram to the Preparticipation Examition of College Athletes

    , 2010

    A New Era in Clinical Genetic Testing for Hypertrophic Cardiomyopathy

    , 2009

    Insights into Human beta-Cardiac Myosin Function from Single Molecule and Single Cell Studies

    , 2009

    Endogenous regulation of cardiovascular function by apelin-APJ

    , 2009

    The Medical Device Safety Act of 2009: Clarifying Preemption

    , 2009

    Electrocardiographic predictors of atrial fibrillation

    , 2009

    Untitled

    , 2009

    Mechanisms of exercise intolerance in patients with hypertrophic cardiomyopathy

    , 2009

    The ageing athlete: screening prior to vigorous exertion in asymptomatic adults

    , 2009

    Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation

    , 2009

    Should the exercise ECG be used to screen for sudden cardiac death?

    , 2009

    Statin Use and Ventricular Arrhythmias During Clinical Treadmill Testing

    , 2009

    A general framework for dose optimization.

    , 2009

    Age and Double Product

    , 2008

    Apelin sigling antagonizes Ang II effects in mouse models of atherosclerosis

    , 2008

    Progressive dyspnea after CABG: Complication of retained epicardial pacing wires

    , 2008

    Low-dose growth hormone is cardioprotective in uremia

    , 2008

    Genetics of Arrhythmia: Disease Pathways Beyond Ion Channels

    , 2008

    Does size matter? Clinical applications of scaling cardiac size and function for body size

    , 2008

    Pharmacogenetics of Heart Failure: Evidence, Opportunities

    , 2008

    Ventricular arrhythmias during clinical treadmill testing and prognosis

    , 2008

    Matrix metalloproteise circulating levels, genetic polymorphisms

    , 2007

    Frontiers in nephrology: Genomic approaches to understanding the molecular basis of atherosclerosis

    , 2007

    Magnetic resonce imaging of progressive cardiomyopathic changes in the db/db mouse

    , 2007

    Prognostic value of heart rate increase at onset of exercise testing

    , 2007

    Emerging therapies for the magement of decompensated heart failure - From bench to bedside

    , 2006

    Network alysis of human in-stent restenosis

    , 2006

    Opposing cardiovascular roles for the angiotensin and apelin sigling pathways

    , 2006

    Perioperative cardiac risk: pathophysiology, assessment and magement.

    , 2006

    Angiotensin-converting enzyme genotype predicts cardiac

    , 2006

    Plasma concentrations of the novel peptide apelin are decreased

    , 2006

    Pathway alysis of corory atherosclerosis

    , 2005

    Sigture patterns of gene expression in mouse atherosclerosis

    , 2005

    Preoperative cardiac evaluation: mechanisms, assessment, and reduction of risk.

    , 2005

    Mouse strain-specific differences in vascular wall gene expression

    , 2005

    The endogenous peptide apelin potently improves cardiac contractility

    , 2005

    Transcriptiol profiling of in vitro smooth muscle cell differentiation

    , 2004

    Electrocardiographic arrhythmia risk testing

    , 2004

    Nitric oxide control of cardiac function: is neurol nitric oxide synthase a key component?

    , 2004

    Cardiology Explained

    Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction

    , 2003

    Cardiac neurol nitric oxide synthase isoform regulates myocardial contraction and calcium handling

    , 2003

    Exercise testing scores as an example of better decisions through science

    , 2002

    Cardiac nitric oxide synthase 1 regulates basal

    , 2002

    Diagnosing corory artery disease in diabetic patients

    , 2002

    Better decisions through science: Exercise testing scores

    , 2002

    An evidence-based review of the resting electrocardiogram as a screening technique for heart

    , 2001

    Sex, the heart, and sildefil.

    , 2001

    The post myocardial infarction exercise test: still worthy after all of these years

    , 2001

    Exercise testing in clinical medicine

    , 2000

    Computer applications in the interpretation of the exercise electrocardiogram

    , 2000

    Medical education - beyond tomorrow? The new doctor - Asclepiad or Logiatros?

    , 2000

    The prevalence and prognostic significance of electrocardiographic abnormalities

    , 2000

    The prevalence and prognostic significance of electrocardiographic abnormalities.

    , 2000

    Dangerous curves - A perspective on exercise, lactate, and the aerobic threshold

    , 1997

    Hormol responses to graded-resistance, PES-assisted strength training in spil cord-injured

    , 1996

    EVIDENCE OF AUTONOMIC DYSREFLEXIA DURING FUNCTIOL ELECTRICAL-STIMULATION IN INDIVIDUALS WITH SPIL

    , 1993

    ELECTRICAL STIMULATION-ASSISTED ROWING EXERCISE IN SPIL-CORD INJURED PEOPLE - A PILOT-STUDY

    , 1993

    What is Dr. Ashley's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.

    Dr. Ashley's National Provider Identifier (NPI) number is 1497792204.

    What common questions do patients ask about Dr. Ashley?

    Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Ashley

    What is Dr. Euan Ashley's specialty?

    Dr. Ashley is a Cardiologist near Redwood City, CA.

    What does a Cardiologist do?

    An internist specializing in cardiovascular diseases focuses on the diagnosis and management of complex heart and blood vessel conditions, including heart attacks and life-threatening arrhythmias.

    Is this Dr. Euan Ashley affiliated with a ranked Castle Connolly Top Hospital?

    Yes, Dr. Ashley is affiliated with Stanford Health Care - Stanford Hospital, Stanford Health Care - Valleycare, New London Hospital, California Pacific Medical Center - Van Ness Campus, Mills-Peninsula Medical Center which are a Castle Connolly Top Hospitals. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals

    When to see a Cardiologist?: Guides for symptoms, conditions, and treatments

    Understand your symptoms and know when it’s time to see a Cardiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.

    Is Euan Ashley accepting new patients in Redwood City, CA?

    Yes, Dr. Euan Ashley is accepting new patients at this time.

    Does Dr. Euan Ashley offer online booking?

    Please contact Dr. Ashley's office at (650) 498-5710 for information about online booking, telehealth, or to schedule an appointment.

    How can I make an appointment with Euan Ashley?

    Please contact Dr. Ashley's office at (650) 498-5710 for information regarding telehealth appointment availability or for scheduling assistance.

    Other Cardiologist Near Redwood City, CA

    acceptingPatients-iconAccepting patients
    Stanford, CA
    acceptingPatients-iconAccepting patients
    East Palo Alto, CA
    acceptingPatients-iconAccepting patients
    Redwood City, CA
    See All Specialists

    Doctors by Category

    Specialists